From: Safety findings from CENTURION, a phase 3 consistency study of lasmiditan for the acute treatment of migraine
Randomized 1:1:1↓
Attack 1
Attack 2
Attack 3
Attack 4
LTN 100 (N=539)
LTN 100
LTN 200 (N=536)
LTN 200
Control (N=538)
Randomized 1:1→
PBO
LTN 50